|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-4-2
|
|
pubmed:abstractText |
NMDA receptors are involved in the development and maintenance of neuropathic pain. We evaluated the efficacy and safety of intranasal (S)-ketamine, one of the most potent clinically available NMDA receptor antagonists.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1532-2149
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2009 European Federation of International Association for the Study of Pain Chapters. Published by Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
387-94
|
|
pubmed:meshHeading |
pubmed-meshheading:19733106-Administration, Intranasal,
pubmed-meshheading:19733106-Adult,
pubmed-meshheading:19733106-Aged,
pubmed-meshheading:19733106-Algorithms,
pubmed-meshheading:19733106-Anesthetics, Dissociative,
pubmed-meshheading:19733106-Cardiovascular System,
pubmed-meshheading:19733106-Female,
pubmed-meshheading:19733106-Hemodynamics,
pubmed-meshheading:19733106-Humans,
pubmed-meshheading:19733106-Ketamine,
pubmed-meshheading:19733106-Male,
pubmed-meshheading:19733106-Middle Aged,
pubmed-meshheading:19733106-Pain,
pubmed-meshheading:19733106-Pain Measurement,
pubmed-meshheading:19733106-Peripheral Nervous System Diseases,
pubmed-meshheading:19733106-Stereoisomerism
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain.
|
|
pubmed:affiliation |
Department of Anaesthesiology, Ludwig-Maximilians Universität München, Campus Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
